vTv Therapeutics CFO Rudy Howard resigns effective December 1, 2021

vTv Therapeutics Inc.

Rudy Howard resigned as CFO and employee effective Dec 1, 2021; no disagreement on operations.
Severance of $325k/year payable through Dec 31, 2022; potential 2021 discretionary bonus.
Options scheduled to vest in Dec 2021 (83,333 shares) accelerated; other options forfeited.
Medical coverage continued at active-employee cost through Dec 31, 2022.
Separation Agreement includes release, non-disparagement, and cooperation through Dec 31, 2021.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Rudy Howard

Chief Financial Officer

VTVT · vTv Therapeutics Inc.

Effective: 2021-12-01
Filed: December 2, 2021, 6:59 PM ET

On December 1, 2021, (the “Effective Date”) Rudy Howard announced his resignation as Chief Financial Officer and as an employee of vTv Therapeutics Inc. (the “Company”), effective as of the Effective Date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Rudy Howard resigned as Chief Financial Officer at vTv Therapeutics Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On December 1, 2021, (the “Effective Date”) Rudy Howard announced his resignation as Chief Financial Officer and as an employee of vTv Therapeutics Inc. (the “Company”), effective as of the Effective Date.

View on SEC.gov

vTv Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0000950142-21-003867

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.